DuPont Names AnnaMaria DeSalva as Vice President of Corporate Communications

05 Feb 2014 --- DuPont named AnnaMaria DeSalva as Vice President of Corporate Communications. In the newly established role, DeSalva, 45, will be responsible for leading, developing and executing the company’s strategic communications and brand management around the world.

“AnnaMaria’s demonstrated experience in science and technology and leadership in communications is an ideal fit for DuPont’s market-driven science,” said DuPont Senior Vice President James C. Collins, Jr.  “Her expertise in working inclusively with stakeholders makes her ideally suited to lead DuPont’s communications and branding efforts.  AnnaMaria will play a significant role in advancing DuPont’s positioning as the company continues to create sustainable solutions that help solve the pressing challenges facing the world.”

Possessing a diverse technology-based background, DeSalva has more than 20 years of experience in science-related communications and branding, including a variety of progressive leadership positions with Pfizer, Hill & Knowlton, GCI Group and Bristol-Myers Squibb.  Most recently, DeSalva has served as vice president, Corporate Affairs - Biopharma Innovation & Outcomes, at Pfizer where she has been responsible for leading science, medicine, portfolio and strategy corporate affairs.  DeSalva is a board director for the National Campaign to End Obesity as well as for INMED Partnerships for Children and she has served as a risk communications adviser to the U.S. Food and Drug Administration.

“I am honored to join DuPont to lead this key function and help build the company’s brand at a time of growth and transformation,” DeSalva said.  “Strong capabilities and strategy in these areas will help further unlock the value of DuPont’s innovation.”